DDX60: Potential Drug Target Or Biomarker (G55601)

Target Name: DDX60

NCBI ID: G55601

DDX60

DDX60: Potential Drug Target Or Biomarker

DDX60 (FLJ20035) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the homeobox gene family, which is a group of genes that are involved in the development and maintenance of tissues and organs.

The study of DDX60 has been ongoing for several years, and there is some interest in it being potential drug target or biomarker. Several studies have investigated the potential role of DDX60 in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the main interests in DDX60 is its potential as a drug target. The homeobox gene family has been known to be involved in the development and maintenance of many tissues and organs, including the nervous system and endocrine system. DDX60 is known to be involved in the development and maintenance of the kidney, and some studies have suggested that it may have potential as a drug target for diseases that affect the kidneys, such as diabetes and hypertension.

In addition to its potential as a drug target, DDX60 has also been investigated as a biomarker for several diseases. The homeobox gene family is known to be involved in the development and maintenance of many tissues and organs, and DDX60 may be a useful biomarker for diseases that involve the kidneys, such as diabetes and hypertension.

One of the main potential applications of DDX60 as a biomarker is its potential to serve as a diagnostic tool. The homeobox gene family is known to be involved in the development and maintenance of many tissues and organs, and it is possible that DDX60 may be expressed in different tissues and organs at different levels in the body. This could make it a useful biomarker for diseases that involve the kidneys, such as diabetes and hypertension.

Another potential application of DDX60 as a biomarker is its potential to serve as a target for diagnostic tests. The homeobox gene family is known to be involved in the development and maintenance of many tissues and organs, and it is possible that DDX60 may be expressed in different tissues and organs at different levels in the body. This could make it a useful target for diagnostic tests that are used to diagnose diseases that involve the kidneys, such as diabetes and hypertension.

In conclusion, DDX60 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the homeobox gene family, and there is some interest in it being potential drug target or biomarker. Further studies are needed to fully understand the potential role of DDX60 in various diseases.

Protein Name: DExD/H-box Helicase 60

Functions: Positively regulates RIGI- and IFIH1/MDA5-dependent type I interferon and interferon inducible gene expression in response to viral infection. Binds ssRNA, dsRNA and dsDNA and can promote the binding of RIGI to dsRNA. Exhibits antiviral activity against hepatitis C virus and vesicular stomatitis virus (VSV)

The "DDX60 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DDX60 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets